SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
SARS-CoV-2 TESTING AND EFFECT OF COVID-19 ON HIV SCREENING
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
CORONACHEK SARS-COV-2 POINT-OF-CARE ANTIBODY TEST PERFORMANCE IN UGANDA AND BALTIMORE (ABSTRACT
690)
Owen R Baker
National Institutes of Health, Bethesda, MD, USA
COST-EFFECTIVENESS OF SARS-COV-2 RAPID ANTIGEN TESTING IN LOW-RESOURCE SETTINGS (ABSTRACT
691)
Sarah Joy Girdwood
Health Economics and Epidemiology Research Office, Johannesburg, Gauteng, South Africa
CAN'T WORK FROM HOME: POOLED NUCLEIC ACID TESTING OF LABORATORY WORKERS DURING COVID (ABSTRACT
692)
Stephen A Rawlings
University of California San Diego, La Jolla, CA, USA
NEUTRALIZING ANTIBODY DECAY IN PATIENTS WITH MILD OR ASYMPTOMATIC COVID-19 INFECTION (ABSTRACT
693)
Saverio Giuseppe Parisi
University of Padova, Padova, Italy
SARS-COV-2 TESTING IN FLORIDA, ILLINOIS, AND MARYLAND: ACCESS AND BARRIERS (ABSTRACT
694)
Steven J Clipman
Johns Hopkins University, Baltimore, MD, USA
SIGNIFICANT IMPACT OF COVID-19 ON THE FIRST PILLARS OF THE HIV CARE CONTINUUM (ABSTRACT
695)
Kathryn S Hensley
Erasmus Medical Centre, Rotterdam, Netherlands
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|